1258268-37-9Relevant articles and documents
Discovery and SAR of a series of 4,6-diamino-1,3,5-triazin-2-ol as novel non-nucleoside reverse transcriptase inhibitors of HIV-1
Liu, Bin,Lee, Younghee,Zou, Jinming,Petrassi, H. Michael,Joseph, Rhoda W.,Chao, Wenchun,Michelotti, Enrique L.,Bukhtiyarova, Marina,Springman, Eric B.,Dorsey, Bruce D.
scheme or table, p. 6592 - 6596 (2010/12/20)
The discovery and SAR study of a series of 4,6-diamino-1,3,5-triazin-2-ol compounds as novel HIV-1 non-nucleoside reverse transcriptase inhibitors (NNRTIs) are reported. The lead compounds in this series showed excellent activity against wild-type and drug-resistant RT enzymes and viral strains. In addition, compounds from this series demonstrated favorable pharmacokinetic profile in rat. A preliminary modeling study was conducted to understand the binding mode of this series of compounds.